EBNA-2 TRANSACTIVATES A LYMPHOID-SPECIFIC ENHANCER IN THE BAMHI C PROMOTER OF EPSTEIN-BARR-VIRUS

被引:143
作者
SUNG, NS
KENNEY, S
GUTSCH, D
PAGANO, JS
机构
[1] UNIV N CAROLINA,DEPT MICROBIOL,CHAPEL HILL,NC 27514
[2] UNIV N CAROLINA,DEPT MED,CHAPEL HILL,NC 27514
[3] UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27514
关键词
D O I
10.1128/JVI.65.5.2164-2169.1991
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Among the few Epstein-Barr virus (EBV) genes expressed during latency are the Epstein-Barr nuclear antigens (EBNAs), at least one of which contributes to the ability of the virus to transform B lymphocytes. We have analyzed a promoter located in the BamHI-C fragment of EBV which is responsible for the expression of EBNA-1 in some cell lines. Deletion analysis of a 1.4-kb region 5' of the RNA start site has identified a 700-bp fragment that is required for optimal promoter activity in latently infected B lymphocytes, as shown by promoter constructs linked to the chloramphenicol acetyltransferase reporter gene. This fragment is also able to enhance activity, in an orientation-independent manner, of the simian virus 40 early promoter linked to the chloramphenicol acetyltransferase gene. The enhancer element has some constitutive activity in EBV-negative lymphoid cells, which is increased in the presence of the EBNA-2 gene product. Further deletions have shown that the EBNA-2-responsive region requires a 98-bp region that contains a degenerate octamer-binding motif. In epithelial cells there was no enhancer activity regardless of the presence of EBNA-2. These results demonstrate that BamHI-C promoter activity may be dependent not on an enhancer contained in the ori-P, as was previously assumed, but rather on EBNA-2 transactivation of this more proximal enhancer located in the upstream region of the BamHI C promoter itself.
引用
收藏
页码:2164 / 2169
页数:6
相关论文
共 51 条
[1]  
ABBOT SD, 1990, J VIROL, V64, P2156
[2]  
Ausubel F, 1988, CURRENT PROTOCOLS MO
[3]   OBP100 BINDS REMARKABLY DEGENERATE OCTAMER MOTIFS THROUGH SPECIFIC INTERACTIONS WITH FLANKING SEQUENCES [J].
BAUMRUKER, T ;
STURM, R ;
HERR, W .
GENES & DEVELOPMENT, 1988, 2 (11) :1400-1413
[4]   EPSTEIN-BARR VIRUS LATENT INFECTION MEMBRANE-PROTEIN INCREASES VIMENTIN EXPRESSION IN HUMAN B-CELL LINES [J].
BIRKENBACH, M ;
LEIBOWITZ, D ;
WANG, F ;
SAMPLE, J ;
KIEFF, E .
JOURNAL OF VIROLOGY, 1989, 63 (09) :4079-4084
[5]   A PROMOTER FOR THE HIGHLY SPLICED EBNA FAMILY OF RNAS OF EPSTEIN-BARR-VIRUS [J].
BODESCOT, M ;
PERRICAUDET, M ;
FARRELL, PJ .
JOURNAL OF VIROLOGY, 1987, 61 (11) :3424-3430
[6]   EPSTEIN-BARR-VIRUS (EBV) INDUCES EXPRESSION OF B-CELL ACTIVATION MARKERS ON INVITRO INFECTION OF EBV-NEGATIVE B-LYMPHOMA CELLS [J].
CALENDER, A ;
BILLAUD, M ;
AUBRY, JP ;
BANCHEREAU, J ;
VUILLAUME, M ;
LENOIR, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (22) :8060-8064
[7]   EPSTEIN-BARR VIRUS NUCLEAR PROTEIN-2 IS A KEY DETERMINANT OF LYMPHOCYTE-TRANSFORMATION [J].
COHEN, JI ;
WANG, F ;
MANNICK, J ;
KIEFF, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) :9558-9562
[8]   EXPRESSION OF THE EPSTEIN-BARR-VIRUS NUCLEAR PROTEIN-2 IN RODENT CELLS [J].
DAMBAUGH, T ;
WANG, F ;
HENNESSY, K ;
WOODLAND, E ;
RICKINSON, A ;
KIEFF, E .
JOURNAL OF VIROLOGY, 1986, 59 (02) :453-462
[9]   IMMEDIATE-EARLY GENE REGION OF HUMAN CYTOMEGALOVIRUS TRANS-ACTIVATES THE PROMOTER OF HUMAN-IMMUNODEFICIENCY-VIRUS [J].
DAVIS, MG ;
KENNEY, SC ;
KAMINE, J ;
PAGANO, JS ;
HUANG, ES .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) :8642-8646
[10]   NASOPHARYNGEAL CARCINOMA .10. PRESENCE OF EPSTEIN-BARR GENOMES IN SEPARATED EPITHELIAL-CELLS OF TUMORS IN PATIENTS FROM SINGAPORE, TUNISIA AND KENYA [J].
DESGRANGES, C ;
WOLF, H ;
DETHE, G ;
SHANMUGARATNAM, K ;
CAMMOUN, N ;
ELLOUZ, R ;
KLEIN, G ;
LENNERT, K ;
MUNOZ, N ;
ZURHAUSEN, H .
INTERNATIONAL JOURNAL OF CANCER, 1975, 16 (01) :7-15